Acetamide → HCID 69946643、化合物

HRID 1281671ノート

反応式

HRID 1281671 の反応式
[Cl:1][C:2]1[C:10]([CH3:11])=[CH:9][C:5]2[N:6]=[CH:7][NH:8][C:4]=2[CH:3]=1.C(N)(=O)C.O([Si](C)(C)C)S(C(F)(F)F)(=O)=O.C(O[C@@H:32]1[O:49][CH2:48][C@@H:43]([O:44][C:45](=[O:47])[CH3:46])[C@@H:38]([O:39][C:40](=[O:42])[CH3:41])[C@H:33]1[O:34][C:35](=[O:37])[CH3:36])(=O)C.C(=O)(O)[O-].[Na+]>ClCCCl>[Cl:1][C:2]1[C:10]([CH3:11])=[CH:9][C:5]2[N:6]([C@@H:48]3[O:49][CH2:32][C@@H:33]([O:34][C:35](=[O:37])[CH3:36])[C@@H:38]([O:39][C:40](=[O:42])[CH3:41])[C@H:43]3[O:44][C:45](=[O:47])[CH3:46])[CH:7]=[N:8][C:4]=2[CH:3]=1

参加物

7

反応物 5

HCID 178AcetamideHCID 65367Trimethylsilyl triflateHCID 97336beta-D-Ribopyranose, 1,2,3,4-tetraacetateHCID 516892Sodium BicarbonateHCID 178422326HCID 178422326、化合物

生成物 1

HCID 69946643HCID 69946643、化合物

試薬・触媒・溶媒 1

HCID 111,2-Dichloroethane溶媒

実験手順

As described in General Procedure III, 5-chloro-6methylbenzimidazole (1.0 g, 6 mmol), N,O-bis(trimethylsiyl) acetamide (Aldrich, 1.3 ml, 5.2 mmol), and 1,2-dichloroethane (Aldrich Sure Seal, 300 mL) were combined and refluxed under nitrogen for 0.5 h. The solution was cooled to room temperature and trimethylsilyl triflate (Aldrich, 1.3 ml, 6.7 mmol) was added. Immediately, 2.0 g (6.3 mmol) solid 1,2,3,4-tetra-O-acetyl-b-D-ribopyranose (beta-D-ribopyranose 1,2,3,4-tetraacetate, Aldrich, Milwaukee) was added. The solution was stirred under nitrogen at reflux overnight, then poured into 7% aqueous sodium bicarbonate and extracted with chloroform. The organic layer was dried with magnesium sulfate (anhyd), filtered, and evaporated. The crude residue was purified on a silica gel column (5×20 cm, 230-400 mesh) eluting with a step gradient of 0.25 to 2.5% methanol in chloroform to give 0.07 g (0.16 mmol) 5-Chloro-6-methyl-(2,3,4-tri-O-acetyl-beta-D-ribopyranosyl)-1H-benzimidazole; MS (AP+): m/z (rel. intensity) 447 (1.0, M+23 (Na)) 1H NMR (DMSO-d6) δ8.36 (s,1H), 7.90 (s, 1H), 7.68 (s, 1H), 5.97-5.95 (d, 1H, J=9.1 Hz), 5.72-5.69 (m, 2H), 5.41-5.40 (m, 1H), 4.02-3.92 (m, 2H), 2.42 (s, 3H), 2.20 (s, 3H), 1.98 (s, 3H), 1.69 (s, 3H) and 0.090 g (0.21 mmol) 6-Chloro-5-methyl-(2,3,4-tri-O-acetyl-beta-D-ribopyranosyl)-1H-benzimidazole 1H NMR (DMSO-d6) δ8.36 (s,1H), 8.06 (s, 1H), 7.60 (s, 1H), 5.99-5.96 (d, 1H, J=9.6 Hz), 5.73-5.66 (m, 2H), 5.45-5.40 (m, 1H), 4.02-3.92 (m, 2H), 2.37 (s, 3H), 2.20 (s, 3H), 1.98 (s, 3H), 1.69 (s, 3H) and 0.13 g (0.31 mmol) of a mixture of the two regioisomers (11% total yield).

後処理

  1. temperaturerefluxed under nitrogen for 0.5 h
  2. temperatureat reflux overnight
  3. extractionextracted with chloroform
  4. dry with materialThe organic layer was dried with magnesium sulfate (anhyd)
  5. filtrationfiltered
  6. customevaporated
  7. customThe crude residue was purified on a silica gel column (5×20 cm, 230-400 mesh)
  8. washeluting with a step gradient of 0.25 to 2.5% methanol in chloroform

出典と根拠

ORDレコード
ord-d5114685ac89480fa3413e8f0b8fd8a3
出典データセット
uspto-grants-2002_09
特許番号
US06455507B1

反応ノート

読み込み中…